Profile data is unavailable for this security.
About the company
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (68 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, Aledex, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revyve are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
- Revenue in CAD (TTM)757.12k
- Net income in CAD-5.48m
- Incorporated2003
- Employees--
- LocationKane Biotech Inc290-100 Innovation DriveWINNIPEG R3T 6G2CanadaCAN
- Phone+1 (204) 453-1301
- Fax+1 (204) 474-7552
- Websitehttps://kanebiotech.com/